Literature DB >> 85726

Analysis of specific proteins in prostatic fluid for detecting prostatic malignancy.

J T Grayhack, E F Wendel, L Oliver, C Lee.   

Abstract

In an attempt to identify an indicator(s) specifically associated with prostatic cancer prostatic fluid was collected by rectal massage from patients with prostatic cancer, prostatitis, benign prostatic hyperplasia and from those without recognized prostatic lesions in order to measure various immunoproteins. The proteins examined were IgG, IgA, IgM, complements C3 and C4, and transferrin. Prostatic fluid samples were subjected first to immunoelectrophoresis. Distinct differences in C3, C4 and transferrin concentrations were noted between patients with prostatic cancer and other patients. These proteins were stained heavily in the electrophoresis gels of fluid from cancer patients but were either missing or lightly stained in all other groups. These qualitative determinations were replaced subsequently by a quantitative measurement using the radial immunodiffusion technique. Results of the latter study confirmed the aforementioned observations and indicated that the levels of C3, C4 and transferrin in the prostatic fluid of cancer patients were elevated significantly when compared to all other patient groups. These observations indicate that the measurement of complements C3 and C4, and transferrin in the prostatic fluid may assist in the identification of patients with a high risk of prostatic cancer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85726     DOI: 10.1016/s0022-5347(17)56760-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Immunoglobulins in tissues of human benign prostatic hypertrophy.

Authors:  M van Sande; K van Camp
Journal:  Urol Res       Date:  1983

2.  Total protein and acid phosphatase concentrations in prostatic fluid from patients with BPH compared to carcinoma.

Authors:  E D Kim; N D Smith; J T Grayhack
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  Alpha 1-antitrypsin, alpha 2-macroglobulin and complement C4 in human benign prostatic hyperplasia.

Authors:  M van Sande; K Van Camp
Journal:  Urol Res       Date:  1983

4.  Use of a solid-phase radioimmunoassay and formalin-fixed whole bacterial antigen in the detection of antigen-specific immunoglobulin in prostatic fluid.

Authors:  L M Shortliffe; N Wehner; T A Stamey
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 5.  Chronic bacterial prostatitis: theoretical and experimental considerations.

Authors:  P O Madsen; K M Jensen; P Iversen
Journal:  Urol Res       Date:  1983

6.  Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers.

Authors:  C Nicole Rosenzweig; Zhen Zhang; Xiaer Sun; Lori J Sokoll; Katherine Osborne; Alan W Partin; Daniel W Chan
Journal:  J Urol       Date:  2009-01-20       Impact factor: 7.450

7.  Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.

Authors:  Brian Grindel; Quanlin Li; Rebecca Arnold; John Petros; Majd Zayzafoon; Mark Muldoon; James Stave; Leland W K Chung; Mary C Farach-Carson
Journal:  Oncotarget       Date:  2016-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.